These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6731025)

  • 1. Inhibition of platelet aggregation by cepharanthine is accomplished during the early, membrane-related activation process.
    Watanabe S
    Acta Med Okayama; 1984 Apr; 38(2):101-15. PubMed ID: 6731025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of cepharanthine on collagen-induced activation in rabbit platelets.
    Kometani M; Kanaho Y; Sato T; Fujii T
    Eur J Pharmacol; 1985 Apr; 111(1):97-105. PubMed ID: 3926512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effect of biscoclaurine alkaloids on agonist-induced activation of phospholipase A2 in rabbit platelets.
    Hashizume T; Yamaguchi H; Sato T; Fujii T
    Biochem Pharmacol; 1991 Feb; 41(3):419-23. PubMed ID: 1899790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug.
    Okimasu E; Moromizato Y; Watanabe S; Sasaki J; Shiraishi N; Morimoto YM; Miyahara M; Utsumi K
    Acta Med Okayama; 1983 Oct; 37(5):385-91. PubMed ID: 6689106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.
    Chen YY; Kwan CY; Hui SC
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):105-8. PubMed ID: 9772654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of metabolic response of polymorphonuclear leukocyte by biscoclaurine alkaloids.
    Matsuno T; Orita K; Sato E; Nobori K; Inoue B; Utsumi K
    Biochem Pharmacol; 1987 May; 36(10):1613-6. PubMed ID: 3036151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies on the chemical modifications of Ehrlich ascites tumor cell membranes by hydrophobic drugs (cepharanthine, papaverine and cholesterol) (author's transl)].
    Shinozawa S; Araki Y
    Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):207-14. PubMed ID: 535824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological intervention with platelet phospholipase A2.
    Nosal R; Jancinova V
    Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E inhibits the release of calcium from a platelet fraction in vitro.
    Butler AM; Gerrard JM; Peller J; Stoddard SF; Rao GH; White JG
    Prostaglandins Med; 1979 Mar; 2(3):203-16. PubMed ID: 121605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certain membrane-interacting amphiphiles inhibit aggregation and reverse shape change of rabbit platelets pre-activated with arachidonic acid through dissociation of cytoskeletal assembly.
    Sato T; Kometani M; Fujii T
    Thromb Res; 1987 May; 46(4):587-92. PubMed ID: 3112994
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
    Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
    Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of 4'-O-substituted 1-benzylisoquinolines with respect to their actions on the cell membrane of blood platelets and erythrocytes.
    Fujii T; Sato T; Tamura A; Kometani M; Nakao K; Fujitani K; Kodama K; Akasu M
    Eur J Pharmacol; 1988 Feb; 146(2-3):285-90. PubMed ID: 3131148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet arachidonic acid liberation by endothelium-derived relaxing factor (EDRF) as studied with sin-1, a nitric oxide generating drug. Evidence for calcium-dependent and calcium-independent mechanisms.
    Gassama-Diagne A; Simon MF; Chap H
    J Lipid Mediat; 1992 Feb; 5(1):61-75. PubMed ID: 1327266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of neferine on platelet aggregation in rabbits].
    Yu J; Hu WS
    Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change.
    Greco NJ; Tenner TE; Tandon NN; Jamieson GA
    Blood; 1990 May; 75(10):1989-90. PubMed ID: 2337670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
    Zhang M; Zhang LZ; Lu JS
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p-Bromophenacyl bromide potentiates hydrogen peroxide formation in human platelets challenged by thrombin and inhibits aggregation.
    Leoncini G; Aprile B; Maresca M
    Biochem Mol Biol Int; 1993 Feb; 29(2):317-25. PubMed ID: 8495215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phospholipid dynamics and function in cell membrane of blood cells. With reference to mode of action of certain amphiphilic drugs].
    Fujii T
    Yakugaku Zasshi; 1994 Jun; 114(6):374-87. PubMed ID: 8051627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.